June 1, 2021 09:06 AM EDTUpdated 10:55 AM

Covid-19 roundup: Moderna submits vaccine for full approval; WHO unveils new Greek-based system for naming variants

Josh Sullivan

Zachary Brennan

Senior Editor

Moderna has initiated its BLA submission process with the FDA to license its Covid-19 vaccine in adults 18 and older, the company announced Tuesday. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna submits vaccine for full approval; WHO unveils new Greek-based system for naming variants

Josh Sullivan

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Mod­er­na sub­mits vac­cine for full ap­proval; WHO un­veils new Greek-based sys­tem for nam­ing vari­ants

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Moderna submits vaccine for full approval; WHO unveils new Greek-based system for naming variants